Get notified when ISPC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Defective Corporate Act - Prior Reverse Split Improperly Executed (new) — The September 2024 reverse split was legally defective due to missing Delaware filing, raising questions about corporate governance oversight and internal controls.
- Second Reverse Split In Under Two Years (new) — Multiple reverse splits in short succession typically signal persistent stock price weakness and potential ongoing compliance challenges with exchange listing requirements.
iSpecimen completes 1-for-40 reverse stock split to regain Nasdaq compliance
Filed May 1, 2026 · Period ending April 29, 2026 · ~1 min read
Key Changes
-
high
Executed 1-for-40 reverse stock split effective April 27, reducing outstanding shares from 52.6M to 1.3M to meet Nasdaq's minimum bid price requirement and avoid delisting.
Item 5.03 verify on EDGAR → -
high
Company disclosed that a prior 1-for-20 reverse split from September 2024 was defective because required Delaware filing was never submitted; Board ratified this error on April 29, 2026.
Item 5.03 verify on EDGAR → -
medium
All stock options, warrants, and restricted stock units were proportionately adjusted for the split; fractional shares were rounded up to benefit shareholders.
Item 5.03 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade ISPC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify